40440-12-8

Basic information

• Product Name: 3-hydrazinopropan-1-ol dihydrochloride
• Synonyms: 3-hydrazinopropan-1-ol dihydrochloride;3-HYDRAZINYLPROPAN-1-OL;3-hydrazino-1-propanol
• CAS NO: 40440-12-8
• Molecular Formula: C₃H₁₀N₂O
• Molecular Weight: 163.05
• Mol File: 40440-12-8.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 102-104 °C(Press: 0.6 Torr)
• Appearance: /
• Density: 1.023±0.06 g/cm3(Predicted)
• PKA: 15.04±0.10(Predicted)
• CAS DataBase Reference: 3-hydrazinopropan-1-ol dihydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3-hydrazinopropan-1-ol dihydrochloride(40440-12-8)
• EPA Substance Registry System: 3-hydrazinopropan-1-ol dihydrochloride(40440-12-8)

Safety Data

• Hazardous Substances Data: 40440-12-8(Hazardous Substances Data)

Upstream product

• 627-30-5 1-chloro-3-hydroxypropane 

Downstream Products

• 5346-33-8 5-nitro-furfural-[2-(3-hydroxy-propyl)-semicarbazone] 
• 4341-15-5 N-(5-Nitro-2-furfuryliden)-3-amino-3,4,5,6-tetrahydro-1,3-oxazin-2-on 
• 81930-33-8 1-(3-hydroxypropyl)-3,5-dimethyl-1H-pyrazole 
• 84102-05-6 3-Benzyloxymethyl-1,5,6,7-tetrahydro-1-(3-hydroxypropyl)-6-methyl-4H-indazol-4-on 
• 91441-69-9 5-chloro-2-(3-hydroxypropyl)-7,10-bis(phenylmethoxy)anthra[1,9-cd]pyrazol-6(2H)-one 
• 108-59-8 malonic acid dimethyl ester 
• 691881-17-1 3-cyclohexyl-1-(3-hydroxypropyl)-4-(4-methylthiophenyl)pyrazol-5-ol 
• 1176272-74-4 1-(3-hydroxypropyl)-4-(2,4,6-trimethylphenyl)pyrazolidine-3,5-dione 
• 1412895-95-4 C₁₃H₁₄Cl₂N₂O₃ 
• 1221502-38-0 3-[5-(4-fluorophenyl)-3-methyl-1H-pyrazol-1-yl]propan-1-ol 

Relevant articles and documents

Modulators of STING (Stimulator of Interferon Genes)

Compounds of the general formula (I): or a pharmaceutically acceptable salt thereof, processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.

SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS

The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents the treatment of inflammatory diseases and conditions.

POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY

The present invention provides a compound represented by the general formula (I), and a polymerizable composition containing the compound. When the polymerizable composition containing the compound represented by the formula (I) is used to form a filmy product, the resulting filmy product exhibits less change over time in phase difference and reverse wavelength dispersion and when the filmy polymer is irradiated with UV light, peeling from a substrate is unlikely to be caused. Further, the invention provides a polymer obtained through polymerization of the polymerizable composition and an optically anisotropic body obtained using the polymer.